← Back to Clinical Trials
Recruiting NCT01931904

Eye Pressure Lowering Surgery

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Glaucoma
Sponsor Oregon Health and Science University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 46
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2014-02-01
Completion 2026-05

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.

Eligibility Criteria

Inclusion Criteria: * Subjects diagnosed with perimetric open angle glaucoma or chronic angle closure glaucoma. * Subjects scheduled to undergo trabeculectomy or tube shunt surgery Exclusion Criteria: * Best-corrected visual acuity less than 20/40 * Age \< 18 or \>85 years * Refractive error of \> +3.00 D or \< -7.00 D * Previous vision correction surgery such as Laser-Assisted in situ Keratomileusis (LASIK) or Photorefractive Keratectomy (PRK) * Previous intraocular surgery except for uncomplicated cataract extraction with posterior chamber intraocular lens implantation * Diabetic retinopathy * History of heart failure, myocardial infarction, transient ischemic attack or stroke * Other diseases that may cause VF loss or optic disc abnormalities * Inability to clinically view or photograph the optic discs due to media opacity or poorly dilating pupil * Inability to perform reliably on automated VF testing * Life-threatening or debilitating illness making it unlikely patient will succes

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}